Many studies have shown that the PI3K/Akt/mTOR signalling pathway plays a crucial role in the treatment of various cancers, leukaemia, cardiovascular and cerebrovascular diseases and other diseases (126–128). This evidence concerns the gene AKT1 and leukemia.